Search results
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 19 hours agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna Beats Quarterly Estimates as Cost-Cutting Pares Losses
Bloomberg· 23 hours agoModerna Inc. reported a narrower first-quarter loss than Wall Street had expected, as the biotech...
J.P. Morgan downgrades Metagenomi over Moderna deal termination (NASDAQ:MGX)
Seeking Alpha· 16 hours agoJ.P. Morgan has lowered its rating of Metagenomi (NASDAQ:MGX) to neutral, citing the recent...
Moderna (MRNA) Surpasses Market Returns: Some Facts Worth Knowing
Zacks via Yahoo Finance· 6 days agoModerna (MRNA) closed the most recent trading day at $107.97, moving +1.69% from the previous...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 23 hours agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo Finance· 23 hours agoModerna on Thursday reported quarterly revenue that beat Wall Street estimates but came in dramatically lower than the previous year when demand for COVID-19 vaccines was ...
Moderna Focused on Cutting Costs, RSV Vaccine
Bloomberg· 19 hours agoModerna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker expects to...
Moderna’s sales from its only product, the COVID-19 vaccine, fell 91% from last year
AOL· 15 hours agoThe dark days of the pandemic are finally in the past for most of us—and that seems to be reflected in the earnings for Moderna, whose revenue is dependent on sales of its ...
Moderna plants new solid tumor trials for cancer vaccine, weeds PD-1 work after review
FierceBiotech· 19 hours agoMuch of Moderna’s focus is on nabbing FDA approval for a respiratory syncytial virus vaccine, a...
Moderna (MRNA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 4 days agoInvestors' focus will likely be on updates on Moderna's (MRNA) expected RSV vaccine launch and its...